The genetic architecture of autistic traits and negative symptoms in non-affective first-episode psychosis: an exploratory longitudinal study.

Autistic traits and negative symptoms (NS) frequently co-occur in schizophrenia spectrum disorders (SSD), even in early stages such as first-episode psychosis (FEP), complicating both diagnosis and prognosis, as these dimensions strongly influence functional outcomes and may share etiological mechan...

Descripción completa

Detalles Bibliográficos
Autores: Mezquida G, Perez-Ramos A, Guasch-Capella N, Forte MF, Parellada M, Amoretti S, Serra-Navarro M, Galvañ J, Cuesta MJ, Mané A, la Serna E, Mitjans M, Bioque M, García-Rizo C, Segura AG, Group AP
Tipo de recurso: artículo
Fecha de publicación:2026
País:España
Institución:Fundació Sant Joan de Déu
Repositorio:r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
OAI Identifier:oai:dnet:r-fsjd______::023fca00e21493d5338ce7b923971ee9
Acceso en línea:https://fsjd.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=30463
Access Level:acceso abierto
Palabra clave:Autistic traits
First-episode psychosis
Negative symptoms
PANSS Autism Severity Score (PAUSS)
Pathway-specific polygenic score
Polygenic score
Descripción
Sumario:Autistic traits and negative symptoms (NS) frequently co-occur in schizophrenia spectrum disorders (SSD), even in early stages such as first-episode psychosis (FEP), complicating both diagnosis and prognosis, as these dimensions strongly influence functional outcomes and may share etiological mechanisms. This study aims to explore the genetic architecture underlying autistic and NS dimensions, to support early stratification and personalised interventions. 203 non-affective FEP were analysed. Symptom severity was assessed using Positive and Negative Symptom Syndrome (PANSS) derived measures: PANSS-Autism Severity Score (PAUSS) for autistic traits and Marder-factors for NS (NSFS), including subdomains of social reciprocity, communication, restricted-repetitive behaviours (PAUSSsoc, PAUSScom, PAUSSrrb), and expressive deficits (EXP) and motivational/pleasure deficits (MAP). Polygenic scores (PGS) for autism spectrum disorder (PGS(ASD)), schizophrenia (PGS(SZ)), educational attainment (PGS(EA)), and cognitive performance (PGS(CP)), including pathway-specific PGS (pPGS) targeting neurodevelopmental and immune-related processes, were used to examine associations with baseline and one-year autistic and NS dimensions. At baseline, PGS(ASD) showed nominal associations (p < 0.05) with PAUSS-total and NSFS-total. At the subdomain level, PGS(CP) was significantly associated with PAUSScom (p = 0.019), while PGS(ASD) showed significant associations with PAUSSsoc (p = 0.034), PAUSSrrb (p = 0.009, p.adj=0.038) and EXP (p = 0.044). At one-year follow-up, PGS(ASD) remained associated with PAUSSrrb (p = 0.009; p.adj=0.048), but not EXP, and PGS(EA) with PAUSScom (p = 0.023). pPGS analyses showed nominal associations (p < 0.05) between neurodevelopmental and immune pathways and PAUSSrrb, PAUSScom, and EXP. Autistic traits and NS in FEP exhibit marked multidimensionality, with distinct subdomains showing differential genetic underpinnings. Neurodevelopmental and immune-mediated pathways appear particularly relevant to restricted-repetitive traits and expressive deficits, supporting subdomain-level phenotyping as a valuable tool for early patient stratification and for refining the clinical characterisation of SSD.